Why the study?
Does drug-eluting stent reduce target-vessel revascularisation and recurrent myocardial infarction in patients with STEMI undergoing PCI compared to bare-metal stent?
Does drug-eluting stent reduce target-vessel revascularisation and recurrent myocardial infarction in patients with STEMI undergoing PCI compared to bare-metal stent?
In STEMI patients undergoing PCI, DES reduces TVR and recurrent MI compared to BMS without increasing cardiac death or stent thrombosis at 1 year.
No takes yet. Share an insight, caveat, or question.
Supports DES preference over BMS in STEMI PCI; meta-analysis strengthens guideline recommendations with aggregated RCT evidence.
Piscione et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: